Centre Hospitalier Le Vinatier
- Address
- lock Available on a paid plan
Centre Hospitalier Le Vinatier - Psychiatric and Neurodevelopmental Research Center
Centre Hospitalier Le Vinatier is a leading psychiatric research institution specializing in innovative therapeutic approaches for mental health disorders and neurodevelopmental conditions. The center conducts cutting-edge clinical trials exploring novel pharmacological interventions and immunomodulatory therapies for complex psychiatric presentations.
- Autism Spectrum Disorders (ASD) - evaluating pitolisant and pimavanserin for core symptoms and irritability in children and adolescents
- Alcohol Use Disorder (AUD) - investigating sodium oxybate and cannabidiol (CBD) for reducing alcohol consumption and maintaining abstinence
- Psychotic Disorders with Dysimmunity - pioneering immunotherapy approaches for psychiatric symptoms with proven autoimmune components
The center demonstrates particular expertise in substance use disorders and neurodevelopmental conditions, with multiple phase III trials examining both traditional pharmacotherapies and innovative compounds like CBD. Their research portfolio reflects a commitment to addressing treatment-resistant psychiatric conditions through precision medicine approaches, including the evaluation of immunomodulatory therapies for mental disorders. The center's work bridges neuroscience, immunology, and psychiatry to develop targeted interventions for patients with complex psychiatric needs.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Le Vinatier
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of High‑Dose vs Low‑Dose Psilocybin for Relapse Prevention in Severe Alcohol Use Disorder with Comorbid Depression: Randomized Controlled Trial | Centre Hospitalier Universitaire De Nimes | Phase III | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cannabidiol | 1 | Unknown | 2024-12-26 | 2024-12-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.